Supports collaborative and interdisciplinary research aimed at understanding cardiovascular disease development in type 1 diabetes. Focus areas include mechanisms of atherosclerosis, cardiomyopathy, endothelial dysfunction, and cardiac autonomic neuropathy. The award continues the CaRe-T1D consortium's work to address residual cardiovascular risk despite optimal management of traditional factors.
Eligible applicants include a wide range of U.S. entities such as state and local governments, federally recognized tribal governments, higher education institutions, nonprofits, small businesses, and others as specified in the announcement.
